Jackson C M
Baillieres Clin Haematol. 1990 Jul;3(3):483-504. doi: 10.1016/s0950-3536(05)80015-0.
Heparin catalysis of clotting proteinase inactivation occurs most efficiently through the reaction of the proteinase with the antithrombin-heparin complex. The efficiency of a heparin molecule in this reaction depends on the presence of a specific pentasaccharide sequence in it, and its molecular weight. The mechanism by which such high affinity heparin acts when antithrombin III is the inhibitor is promotion of the formation of an intermediate proteinase-heparin-antithrombin complex. Heparin promotion of thrombin inactivation by heparin cofactor II may occur by a similar mechanism. The requirement for a specific oligosaccharide sequence within the heparin molecule does not, however, exist for heparin cofactor II. Binding of heparin to both thrombin and antithrombin III interferes with thrombin inactivation. This binding is very dependent on the ionic strength of the reaction mixture and may explain some of the discordant results and interpretations from early studies on the mechanism of heparin action. Low ionic strength in in vitro reactions also results in cleavage of antithrombin III by thrombin in the presence of heparin and effectively converts antithrombin III from an inhibitor to a substrate.
肝素对凝血蛋白酶失活的催化作用最有效地通过蛋白酶与抗凝血酶 - 肝素复合物的反应发生。肝素分子在该反应中的效率取决于其特定五糖序列的存在及其分子量。当抗凝血酶III作为抑制剂时,这种高亲和力肝素起作用的机制是促进中间蛋白酶 - 肝素 - 抗凝血酶复合物的形成。肝素辅因子II对肝素促进凝血酶失活可能通过类似机制发生。然而,肝素辅因子II对肝素分子内特定寡糖序列并无要求。肝素与凝血酶和抗凝血酶III的结合都会干扰凝血酶失活。这种结合非常依赖于反应混合物的离子强度,这可能解释了早期关于肝素作用机制研究中的一些不一致结果和解释。体外反应中的低离子强度还会导致在肝素存在下凝血酶切割抗凝血酶III,并有效地将抗凝血酶III从抑制剂转变为底物。